This site is intended for UK healthcare professionals only
Fluctuating oestrogen levels and menstrual disorders are associated with increased migraine prevalence during the perimenopause. However, effective symptom management can result in migraine improvement.
The British Menopause Society have published a useful tool advising clinicians on the use of HRT for women with migraine. The tool covers key symptoms and a comparison table highlighting the treatment options available.
We do not endorse, approve, certify, or control any linked websites, their sponsors, or any of their policies, activities, products, or services. We do not assume responsibility for the accuracy, completeness, or timeliness of the information.
Visitors to any linked websites should not use or rely on the information contained therein.
Please click “Continue” to leave this website and proceed to the selected site.
This link takes you to a 3rd party website not controlled by us.
The site may contain information that has been created, published, maintained, or posted by institutions or organisations independent of the PCWHF.
We do not endorse, approve, certify, or control any linked websites, their sponsors, or any of their policies, activities, products, or services. We do not assume responsibility for the accuracy, completeness, or timeliness of the information.
Visitors to any linked websites should not use or rely on the information contained therein.
Please click “Continue” to leave this website and proceed to the selected site.
